Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.6161
+0.0249 (4.21%)
At close: Dec 5, 2025, 4:00 PM EST
0.6099
-0.0062 (-1.01%)
After-hours: Dec 5, 2025, 7:58 PM EST
RVPH Stock Forecast
RVPH's stock price has decreased by -50.71% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 6 professional analysts, the 12-month price target for RVPH stock ranges from a low of $2.00 to a high of $7.00. The average analyst price target of $3.33 forecasts a 440.50% increase in the stock price over the next year.
Price Target: $3.33 (+440.50%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for RVPH stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $2 | Strong Buy | Maintains | $2 | +224.62% | Nov 19, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $2 | Strong Buy | Maintains | $2 | +224.62% | Oct 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $4 | Strong Buy | Maintains | $11 → $4 | +549.25% | Oct 27, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $2 | Strong Buy | Initiates | $2 | +224.62% | Sep 29, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $3 → $2 | Strong Buy | Maintains | $3 → $2 | +224.62% | Sep 19, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
2.91M
EPS This Year
-0.41
from -0.90
EPS Next Year
-0.30
from -0.41
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | 21.0M | ||||
| Avg | n/a | 2.9M | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.32 | - | ||||
| Avg | -0.41 | -0.30 | ||||
| Low | -0.49 | -0.83 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.